{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:41:50Z","timestamp":1789180910753,"version":"build-2803163510"},"reference-count":55,"publisher":"Informa UK Limited","issue":"11-12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Metabolism &amp; Toxicology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1080\/17425255.2024.2402496","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T03:46:20Z","timestamp":1726026380000},"page":"1003-1011","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["A pharmacokinetic and pharmacodynamic evaluation of asundexian: a novel factor XIa inhibitor for stroke prevention"],"prefix":"10.1080","volume":"20","author":[{"given":"Arianna","family":"Cella","sequence":"first","affiliation":[{"name":"Clinical Neurology, Department of Head, Neck and Neurosciences, Udine University Hospital, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mar\u00e8","sequence":"additional","affiliation":[{"name":"Clinical Neurology, Department of Head, Neck and Neurosciences, Udine University Hospital, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luigi","family":"Gigli","sequence":"additional","affiliation":[{"name":"DMED, University of Udine, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialuisa","family":"Zedde","sequence":"additional","affiliation":[{"name":"Neurology Unit, Department of Neuromotor Physiology and Rehabilitation, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Valente","sequence":"additional","affiliation":[{"name":"Clinical Neurology, Department of Head, Neck and Neurosciences, Udine University Hospital, Udine, Italy"},{"name":"DMED, University of Udine, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6525-9529","authenticated-orcid":false,"given":"Giovanni","family":"Merlino","sequence":"additional","affiliation":[{"name":"Clinical Neurology, Department of Head, Neck and Neurosciences, Udine University Hospital, Udine, Italy"},{"name":"Stroke Unit, Department of Head, Neck and Neurosciences, Udine University Hospital, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,10,7]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000375"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.113.675140"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.062353"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62343-0"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2023.04.021"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2021.11.053"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017101"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-571232"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.10.038"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvab062"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300235"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.27188"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813959"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1802686"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvab043"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32409-1"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33365-2"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1730-8725"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-023-00838-4"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-199182"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15700"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-277798"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-540872"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-120139"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12856"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-05-0307"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-742262"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003093421004"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.4081\/btvb.2023.76"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2023.02.008"},{"key":"e_1_3_4_33_1","unstructured":"Asundexian molecular formula. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Asundexian#section=Molecular-Formula"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15439"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c00795"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15230"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2024.03.001"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1207"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15981"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2023.151484"},{"key":"e_1_3_4_41_1","unstructured":"Study to assess the safety tolerability effects on the body absorption distribution and elimination of 25 mg BAY2433334 in renal impairment including renal replacement therapy (\u2018dialysis\u2019). Available from: https:\/\/clinicaltrials.gov\/study\/NCT04510987"},{"key":"e_1_3_4_42_1","unstructured":"A study to learn how the study treatment asundexian moves into through and out of the body how it works how safe it is and how it affects the body in participants with mild or moderate reduction of liver function compared to participants with normal liver function. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05419635"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00456-1"},{"key":"e_1_3_4_44_1","unstructured":"OCEANIC-AF clinical trial. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05643573"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01588-4"},{"key":"e_1_3_4_46_1","unstructured":"OCEANIC-STROKE clinical trial. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT05686070"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.123.043198"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.12.004"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1177\/17474930231216339"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2013.07.009"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13299"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300615"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2209051"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac242"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-848333"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdmv.2023.04.002"},{"key":"e_1_3_4_57_1","unstructured":"OCEANIC-AFINA clinical trial. Available from: https:\/\/www.bayer.com\/media\/en-us\/new-asundexian-phase-iii-study-to-include-patients-with-atrial-fibrillation-ineligible-for-oral-anticoagulant-treatment\/"}],"container-title":["Expert Opinion on Drug Metabolism &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2024.2402496","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T06:14:19Z","timestamp":1733292859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425255.2024.2402496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":55,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1080\/17425255.2024.2402496"],"URL":"https:\/\/doi.org\/10.1080\/17425255.2024.2402496","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}